W80 bil. Stillen market will heat up

Published: 2008-09-11 06:53:00

Updated: 2008-09-11 06:53:00

Many major pharmaceutical manufacturers will rush to introduce the first version of Stillen capsule, one of Dong-A Pharmaceutical’s flagship products for treatment of gastritis, as the re-examination period of this medicine expired on June 11.

Stillen was developed by joint researches among th...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK